https://www.thebodypro.com/category/prezista-pro/tag/cardiovascular
Darunavir (Prezista)

Cardiovascular

The Latest

Boosted Darunavir Is Associated With Higher Cardiovascular Risk in D:A:D Study, but Not Atazanavir Img

Boosted Darunavir Is Associated With Higher Cardiovascular Risk in D:A:D Study, but Not Atazanavir

Cumulative use of the boosted protease inhibitor darunavir/ritonavir was associated with an approximately 60% higher rate of developing heart disease over five years, in an analysis from the D:A:D study.